Rhythm Pharmaceuticals Inc
NASDAQ:RYTM

Watchlist Manager
Rhythm Pharmaceuticals Inc Logo
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
Watchlist
Price: 59.705 USD 1.14% Market Closed
Market Cap: 3.7B USD
Have any thoughts about
Rhythm Pharmaceuticals Inc?
Write Note

Relative Value

The Relative Value of one RYTM stock under the Base Case scenario is 55.247 USD. Compared to the current market price of 59.705 USD, Rhythm Pharmaceuticals Inc is Overvalued by 7%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RYTM Relative Value
Base Case
55.247 USD
Overvaluation 7%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
41
vs Industry
25
Median 3Y
35.3
Median 5Y
29.6
Industry
7.7
Forward
28.9
vs History
vs Industry
Median 3Y
-8.1
Median 5Y
-7.9
Industry
22.7
Forward
-13.3
vs History
vs Industry
Median 3Y
-8.4
Median 5Y
-8.1
Industry
21.6
vs History
vs Industry
Median 3Y
-13
Median 5Y
-9.4
Industry
25.2
vs History
4
vs Industry
1
Median 3Y
5.9
Median 5Y
5.1
Industry
2.5
vs History
31
vs Industry
23
Median 3Y
29.6
Median 5Y
26.3
Industry
7.7
Forward
27.4
vs History
33
vs Industry
17
Median 3Y
34.5
Median 5Y
29.6
Industry
9
vs History
vs Industry
Median 3Y
-6.4
Median 5Y
-5.3
Industry
4.2
Forward
-12.4
vs History
vs Industry
Median 3Y
-6.3
Median 5Y
-5.3
Industry
4.1
Forward
-12.4
vs History
vs Industry
Median 3Y
-7
Median 5Y
-6
Industry
5.7
vs History
vs Industry
Median 3Y
-6.9
Median 5Y
-6
Industry
3.6
vs History
26
vs Industry
5
Median 3Y
29.1
Median 5Y
41.7
Industry
4.6

Multiples Across Competitors

RYTM Competitors Multiples
Rhythm Pharmaceuticals Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
3.7B USD 32.6 -14 -13.2 -13.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 888 840.5 -180 080 -218 674.5 -216 179.2
US
Abbvie Inc
NYSE:ABBV
314.7B USD 5.7 61.9 15.4 23.7
US
Amgen Inc
NASDAQ:AMGN
157B USD 4.8 37.1 17.4 32.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD 10.9 -241.6 24 25.2
US
Gilead Sciences Inc
NASDAQ:GILD
112.2B USD 4 890.3 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 859.4 -474.5 -516.7 -502.9
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 6 17.8 16.2 18
US
Seagen Inc
F:SGT
39.3B EUR 17.9 -54.9 -59 -53.2
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.6 -130.6 -105.1 -76.6
P/E Multiple
Earnings Growth
US
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
Average P/E: 208
Negative Multiple: -14
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -180 080 N/A
US
Abbvie Inc
NYSE:ABBV
61.9
412%
US
Amgen Inc
NASDAQ:AMGN
37.1
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -241.6
42%
US
Gilead Sciences Inc
NASDAQ:GILD
890.3
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -474.5 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.9 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -130.6 N/A
EV/EBITDA Multiple
EBITDA Growth
US
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
Average EV/EBITDA: 17.2
Negative Multiple: -13.2
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -218 674.5 N/A
US
Abbvie Inc
NYSE:ABBV
15.4
28%
US
Amgen Inc
NASDAQ:AMGN
17.4
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
38%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -516.7 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -105.1 N/A
EV/EBIT Multiple
EBIT Growth
US
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
Average EV/EBIT: 22.5
Negative Multiple: -13.1
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 179.2 N/A
US
Abbvie Inc
NYSE:ABBV
23.7
88%
US
Amgen Inc
NASDAQ:AMGN
32.9
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -502.9 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.2 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.6 N/A

See Also

Discover More
Back to Top